stride semaglutide Best of ACC 2025 and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE) Semaglutide increased walking distance in patients with symptomatic peripheral artery disease and STRIDE - Semaglutide and walking

This review covers the pathophysiology and treatment of type 2 diabetes mellitus in the context of coronavirus infection

GLP-1s are often talked about as weight-loss drugs

50(5): 4418 Kerner J, Hoppel C

In contrast, if you experience side effects such as severe abdominal pain, gastrointestinal issues, constipation, diarrhea, pancreatitis (inflammation of the pancreas), gallbladder problems, kidney issues, or vision changes, your dosage may need an adjustment

Risks of Inconsistent Dosing Semaglutide and tirzepatide require precise dosing to achieve optimal results and minimize side effects

Passive immunization is based on the hypothesis that chronic intravenous administration of antibodies will halt the formation and spreading of pathogenic -syn aggregates, and potentially modify the disease course